NeueHealth, Inc. (NEUE)

NeueHealth, Inc. was formerly Bright Health Group, Inc., a healthcare company established in 2015. It began as an insurer offering health plans in the commercial, Medicare Advantage, and Affordable Care Act marketplace segments. Over time, the company shifted away from insurance toward direct care delivery and services for providers.

Bright Health listed its stock on the New York Stock Exchange in June 2021 under the symbol BHG. In the years that followed it exited most of its insurance operations, including the sale of its Medicare Advantage business, and carried out a reverse stock split. In January 2024 the company rebranded as NeueHealth and began trading under the symbol NEUE.

After the transition, NeueHealth operated through two segments. NeueCare provided healthcare services through owned and affiliated clinics under brands such as Centrum Health, AssociatesMD, and Premier Medical Associates. The clinics served patients in the ACA marketplace, Medicare, and Medicaid, with pharmacy, laboratory, and radiology services, plus chronic care management and care coordination.

The second segment, NeueSolutions, supported healthcare providers and medical groups participating in performance-based reimbursement arrangements, including Medicare programs that reward cost and quality outcomes. The company's headquarters moved to Doral, Florida. Its strategy emphasized risk-bearing primary care and value-based models.

New Enterprise Associates, a long-time investor in the company, together with other existing shareholders, proposed taking NeueHealth private. Because NEA and other affiliates were already stockholders, the transaction was a going-private transaction subject to additional disclosure through a Schedule 13E-3. Under the agreement, holders of common stock, other than those rolling over their equity, were to receive $7.33 per share in cash.

The transaction valued NeueHealth at an enterprise value of approximately $1.465 billion. NEA and twelve existing investors, who held all of the outstanding preferred stock, entered into rollover agreements to exchange their shares for equity in the private company. NeueHealth's executive team rolled over all of its equity.

The company announced the closing of the take-private transaction on October 2, 2025, and its Class A common stock ceased trading on the New York Stock Exchange that day. NeueHealth said it intended to file to suspend its periodic reporting obligations and terminate the registration of its securities. Chief Executive Officer Mike Mikan said the business would continue its consumer-centric care model under private ownership.